Your search history is turned on.
Date: April 11, 2024 Jurisdictions: Alberta, British Columbia, Ontario
VIA ELECTRONIC TRANSMISSION TO ALL APPLICABLE EXCHANGES AND COMMISSIONS: RE: BIOREM INC Confirmation of Notice of Record and Meeting Dates We are pleased to confirm that Notice of Record and Meeting Dates was sent to The Canadian Depository for Securities. We advise the following with respect to the upcoming Annual General and Special Meeting of Security Holder...
Microsoft Word - Year End News Release 2023 draft.docx Biorem Reports 2023 Financial Results including $0.14 earnings per share Guelph, Ontario April 11, 2024 BIOREM Inc. (TSX-V: BRM) (Biorem or the Company) today announced its results for the three and twelve-month periods ended December 31, 2023. Biorems complete fiscal 2023 year-end financial statements a...
Microsoft Word - Biorem - Annual CFO Cert Dec 31-23 Yr End(61850452.1).docx GPSTRK013919 FORM 52-109FV1 CERTIFICATION OF ANNUAL FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Douglas Newman, Chief Financial Officer of Biorem Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for ...
Microsoft Word - Biorem - Annual CEO Cert - Dec 31-23 Yr End(61850418.1).docx GPSTRK013919 FORM 52-109FV1 CERTIFICATION OF ANNUAL FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Derek Webb, Chief Executive Officer of Biorem Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for gr...
Microsoft Word - fy2023 MDA Q4 Draft(61847519.1).docx 1 BIOREM Inc. MANAGEMENTS DISCUSSION & ANALYSIS (MD&A) For the Year Ended December 31, 2023 Introduction This Management Discussion and Analysis (MD&A) provides information that management believes is relevant to an assessment and understanding of the Companys consolidated results of operations an...
Date: April 11, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, NEWMAN, Douglas, an officer of the reporting issuer noted below have examined this Form 13- 502F1 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reasonab...
Create participation fee form Note: [01 Mar 2017] The following is a consolidation of 13-501F1. It incorporates amendments to this document that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative. FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS PARTICIPATI...
Microsoft Word - Updated Biorem FS 2023(61749539.5) Consolidated Financial Statements of Biorem Inc. December 31, 2023 and 2022 Biorem Inc. December 31, 2023 and 2022 Table of contents Independent Auditors Report ................................................................................................................. 1-4 Consolidate...
Date: November 29, 2023 Jurisdictions: Alberta, British Columbia, Ontario
Microsoft Word - Q3 2023 News Release FINAL.docx Biorem Reports Third Quarter Results, Record Order Backlog and Quarterly EPS of $0.03 Guelph, Ontario November 29, 2023 BIOREM Inc. (TSX-V: BRM) (BIOREM or The Company) today announced its results for the three and nine-month periods ended September 30, 2023. BIOREMs complete second quarter financial statemen...
Date: November 28, 2023 Jurisdictions: Alberta, British Columbia, Ontario
Microsoft Word - MDA Q3 FINAL.docx 1 BIOREM Inc. MANAGEMENTS DISCUSSION & ANALYSIS (MD&A) For the Quarter Ended September 30, 2023 Introduction This Management Discussion and Analysis (MD&A) provides information that management believes is relevant to an assessment and understanding of the Companys consolidated results of operation and financial con...